Solriamfetol 75 MG

DRUG2 trials

Sponsors

Massachusetts General Hospital, University of Pennsylvania

Conditions

Attention Deficit Hyperactivity DisorderInsomnia

Phase 2

A Controlled Study of Solriamfetol for Attention Deficit Hyperactivity Disorder (ADHD) in Adults

CompletedNCT04839562

Massachusetts General HospitalAttention Deficit Hyperactivity Disorder

Start: 2021-08-06End: 2023-01-27Updated: 2024-03-04

Phase 4

Solriamfetol and CBT-I in Patients With Insomnia Disorder

CompletedNCT05838430

University of PennsylvaniaInsomnia

Start: 2023-07-31End: 2026-04-30Updated: 2026-05-12

Related Papers

Solriamfetol for Attention-Deficit/Hyperactivity Disorder in Adults

The Journal of Clinical Psychiatry2023-10-0513 citations